Search Results for “” – Page 12 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes Observational

265 Publications found

Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.

b

Cancers

March 8, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Perioperative Troponin Screening Identifies Patients at Higher Risk for Major Cardiovascular Events in Noncardiac Surgery.

b

Current problems in cardiology

March 1, 2021

p Cardiovascular Disease

c Change patient management Clinical outcomes Observational
MALDI-TOFMS-oriented early definitive therapy improves the optimal use of antibiotics for Enterococcus spp. bloodstream infection.

b

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

February 1, 2021

p MALDI-TOF MS For Microorganism Identification

c Change patient management Clinical outcomes Observational Operational efficiencies
Targeting G1/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4/6 inhibitor-based regimens.

b

JCI insight

January 11, 2021

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
Prospective identification by neonatal screening of patients with guanidinoacetate methyltransferase deficiency.

b

Molecular genetics and metabolism

January 1, 2021

p Newborn Screening

c Change patient management Clinical outcomes Observational
Quality of Life Is Associated with Cardiac Biomarkers, Echocardiographic Indices, and Mortality in CKD Stage 4-5 Patients Not on Dialysis.

b

Blood purification

January 1, 2021

p Cardiovascular Disease

c Clinical outcomes Observational Patient-centeredness
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.

b

Therapeutic advances in medical oncology

January 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Impact of Precision Medicine on Clinical Outcomes: A Single-Institution Retrospective Study.

b

Frontiers in oncology

January 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.

b

Therapeutic advances in medical oncology

January 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
A Phase II Trial of Osimertinib as the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1.

b

Cancer research and treatment

January 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational